Authors:
GASDASKA JR
KIRKPATRICK DL
MONTFORT W
KUPERUS M
HILL SR
BERGGREN M
POWIS G
Citation: Jr. Gasdaska et al., OXIDATIVE INACTIVATION OF THIOREDOXIN AS A CELLULAR GROWTH-FACTOR ANDPROTECTION BY A CYS(73)-]SER MUTATION, Biochemical pharmacology, 52(11), 1996, pp. 1741-1747
Citation: G. Powis et al., INHIBITORS OF PHOSPHOLIPID INTRACELLULAR SIGNALING AS ANTIPROLIFERATIVE AGENTS, Medicinal research reviews, 15(2), 1995, pp. 121-138
Authors:
OBLONG JE
BERGGREN M
GASDASKA PY
HILL SR
POWIS G
Citation: Je. Oblong et al., SITE-DIRECTED MUTAGENESIS OF LYS(36) IN HUMAN THIOREDOXIN - THE HIGHLY CONSERVED RESIDUE AFFECTS REDUCTION RATES AND GROWTH-STIMULATION BUTIS NOT ESSENTIAL FOR THE REDOX PROTEINS BIOCHEMICAL OR BIOLOGICAL PROPERTIES, Biochemistry, 34(10), 1995, pp. 3319-3324
Authors:
POWIS G
OBLONG JE
GASDASKA PY
BERGGREN M
HILL SR
KIRKPATRICK DL
Citation: G. Powis et al., THE THIOREDOXIN THIOREDOXIN REDUCTASE REDOX SYSTEM AND CONTROL OF CELL-GROWTH, Oncology research, 6(10-11), 1994, pp. 539-544
Citation: Sr. Hill et Mc. Bibby, 5-FLUOROURACIL CAUSES ALTERATIONS IN THE PHARMACOKINETIC PROFILE OF TAUROMUSTINE IN NMRI MICE, Cancer chemotherapy and pharmacology, 34(1), 1994, pp. 57-62
Authors:
DIAZCOLLIER JA
PALMIER MO
KRETZMER KK
BISHOP BF
COMBS RG
OBUKOWICZ MG
FRAZIER RB
BILD GS
JOY WD
HILL SR
DUFFIN KL
GUSTAFSON ME
JUNGER KD
GRABNER RW
GALLUPPI GR
WUN TC
Citation: Ja. Diazcollier et al., REFOLD AND CHARACTERIZATION OF RECOMBINANT TISSUE FACTOR PATHWAY INHIBITOR EXPRESSED IN ESCHERICHIA-COLI, Thrombosis and haemostasis, 71(3), 1994, pp. 339-346
Authors:
HILL SR
BONJOUKLIAN R
POWIS G
ABRAHAM RT
ASHENDEL CL
ZALKOW LH
Citation: Sr. Hill et al., A MULTISAMPLE ASSAY FOR INHIBITORS OF PHOSPHATIDYLINOSITOL PHOSPHOLIPASE-C - IDENTIFICATION OF NATURALLY-OCCURRING PEPTIDE INHIBITORS WITH ANTIPROLIFERATIVE ACTIVITY, Anti-cancer drug design, 9(4), 1994, pp. 353-361
Citation: Sr. Hill et Aj. Smith, THE RESPONSE TO ARACHIDONIC-ACID BEFORE AND AFTER NONSTEROIDAL ANTIINFLAMMATORY DRUGS IN NORMOTENSIVE AND HYPERTENSIVE RATS, Journal of hypertension, 12(8), 1994, pp. 891-899